| Year |
Citation |
Score |
| 2021 |
Chung WM, Chen L, Chang WC, Su SY, Hung YC, Ma WL. Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials. International Journal of Molecular Sciences. 22. PMID 34299364 DOI: 10.3390/ijms22147748 |
0.447 |
|
| 2020 |
Lai HC, Chung WM, Chang CM, Liao PY, Su YT, Yeh CC, Jeng LB, Ma WL, Chang WC. Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness. Anticancer Research. 40: 1285-1295. PMID 32132025 DOI: 10.21873/anticanres.14070 |
0.352 |
|
| 2019 |
Yang JC, Chang N, Wu DC, Cheng WC, Chung WM, Chang WC, Lei FJ, Liu CJ, Wu IC, Lai HC, Ma WL. Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer. Journal of Cellular and Molecular Medicine. PMID 31557413 DOI: 10.1111/jcmm.14605 |
0.374 |
|
| 2019 |
Chung WM, Ho YP, Chang WC, Dai YC, Chen L, Hung YC, Ma WL. Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis. Cancers. 11. PMID 30986993 DOI: 10.3390/cancers11040463 |
0.349 |
|
| 2017 |
Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. 8: 74119-74128. PMID 29088772 DOI: 10.18632/oncotarget.18271 |
0.692 |
|
| 2017 |
Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. 8: 69508-69519. PMID 29050220 DOI: 10.18632/oncotarget.17843 |
0.785 |
|
| 2017 |
Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. PMID 28618396 DOI: 10.18632/oncotarget.18271 |
0.692 |
|
| 2017 |
Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. PMID 28562322 DOI: 10.18632/oncotarget.17843 |
0.785 |
|
| 2016 |
Xu J, Lin H, Li G, Sun Y, Shi L, Ma WL, Chen J, Cai X, Chang C. Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals. International Journal of Cancer. PMID 27668844 DOI: 10.1002/Ijc.30446 |
0.491 |
|
| 2016 |
Lai HC, Yeh CC, Jeng LB, Huang SF, Liao PY, Lei FJ, Cheng WC, Hsu CL, Cai X, Chang C, Ma WL. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells. Oncotarget. PMID 27340775 DOI: 10.18632/Oncotarget.10186 |
0.722 |
|
| 2016 |
Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C. Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib Plus NK Cells-Immunotherapy to Better Suppress HCC Progression. Molecular Cancer Therapeutics. PMID 26939703 DOI: 10.1158/1535-7163.Mct-15-0706 |
0.583 |
|
| 2015 |
Chen YH, Chen CJ, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Tsai KS, Wu SY, Chang C, Chen HY, Yeh S. Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence. World Journal of Urology. PMID 25577129 DOI: 10.1007/S00345-014-1474-3 |
0.419 |
|
| 2014 |
Chen YH, Chen CJ, Yeh S, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Chang C, Chen HY. Urethral dysfunction in female mice with estrogen receptor β deficiency. Plos One. 9: e109058. PMID 25275480 DOI: 10.1371/Journal.Pone.0109058 |
0.439 |
|
| 2014 |
Hsu CL, Liu JS, Wu PL, Guan HH, Chen YL, Lin AC, Ting HJ, Pang ST, Yeh SD, Ma WL, Chen CJ, Wu WG, Chang C. Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis. Molecular Oncology. 8: 1575-87. PMID 25091737 DOI: 10.1016/J.Molonc.2014.06.009 |
0.776 |
|
| 2014 |
Ma WL, Jeng LB, Lai HC, Liao PY, Chang C. Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells. Cancer Letters. 351: 64-71. PMID 24944078 DOI: 10.1016/J.Canlet.2014.05.017 |
0.55 |
|
| 2014 |
Chang TY, Chung CY, Chuang WM, Li LY, Jeng LB, Ma WL. Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma. Biomed Research International. 2014: 156356. PMID 24734226 DOI: 10.1155/2014/156356 |
0.322 |
|
| 2014 |
Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocrine-Related Cancer. 21: R165-82. PMID 24424503 DOI: 10.1530/Erc-13-0283 |
0.59 |
|
| 2014 |
Chen L, Chang WC, Hung YC, Chang YY, Bao BY, Huang HC, Chung WM, Shyr CR, Ma WL. Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line. Reproductive Sciences (Thousand Oaks, Calif.). 21: 386-94. PMID 23962788 DOI: 10.1177/1933719113497281 |
0.713 |
|
| 2013 |
Hsieh TF, Chen CC, Ma WL, Chuang WM, Hung XF, Tsai YR, Lin MH, Zhang Q, Zhang C, Chang C, Shyr CR. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation. Oncology Reports. 30: 2917-22. PMID 24126741 DOI: 10.3892/Or.2013.2792 |
0.768 |
|
| 2013 |
Chung WM, Chang WC, Chen L, Chang YY, Shyr CR, Hung YC, Ma WL. MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro. Stem Cell Research & Therapy. 4: 88. PMID 23890123 DOI: 10.1186/scrt247 |
0.63 |
|
| 2013 |
Chen CC, Hsieh TF, Chang CH, Ma WL, Hung XF, Tsai YR, Lin MH, Zhang C, Chang C, Shyr CR. Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2. Oncology Reports. 30: 979-85. PMID 23715826 DOI: 10.3892/Or.2013.2506 |
0.759 |
|
| 2013 |
Hsieh TF, Chen CC, Yu AL, Ma WL, Zhang C, Shyr CR, Chang C. Androgen receptor decreases the cytotoxic effects of chemotherapeutic drugs in upper urinary tract urothelial carcinoma cells. Oncology Letters. 5: 1325-1330. PMID 23599788 DOI: 10.3892/Ol.2013.1140 |
0.75 |
|
| 2013 |
Huang CK, Lee SO, Lai KP, Ma WL, Lin TH, Tsai MY, Luo J, Chang C. Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. Hepatology (Baltimore, Md.). 57: 1550-63. PMID 23150236 DOI: 10.1002/Hep.26135 |
0.753 |
|
| 2013 |
Hsieh TF, Chen CC, Chang CH, Yu AL, Ma WL, Shyr CR. The potential use of primary human upper urinary tract urothelial cell carcinoma (UUT-UCC) cultured cells for prognostic indicators and chemosensitivity test. Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fã¼R Toxikologische Pathologie. 65: 703-8. PMID 23069010 DOI: 10.1016/j.etp.2012.09.003 |
0.684 |
|
| 2013 |
Shyr CR, Chen CC, Hsieh TF, Chang CH, Ma WL, Yeh S, Messing E, Li TH, Li FY, Chang C. The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells. Endocrine. 43: 191-9. PMID 22851332 DOI: 10.1007/S12020-012-9762-4 |
0.739 |
|
| 2012 |
Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology (Baltimore, Md.). 56: 176-85. PMID 22318717 DOI: 10.1002/Hep.25644 |
0.796 |
|
| 2011 |
Hsu JW, Yasmin-Karim S, King MR, Wojciechowski JC, Mickelsen D, Blair ML, Ting HJ, Ma WL, Lee YF. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. The American Journal of Pathology. 178: 872-80. PMID 21281819 DOI: 10.1016/J.Ajpath.2010.10.036 |
0.674 |
|
| 2010 |
Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Science Translational Medicine. 2: 32ra35. PMID 20484730 DOI: 10.1126/Scitranslmed.3001143 |
0.714 |
|
| 2010 |
Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene. 29: 3593-604. PMID 20440270 DOI: 10.1038/Onc.2010.121 |
0.54 |
|
| 2010 |
Ma W, Hsu C, Wu M, Huang C, Hsu J, Chen C, Wu C, Chang C. Abstract 2917: Novel function of androgen receptor: Cancer suppressor in hepatocellular carcinoma Cancer Research. 70: 2917-2917. DOI: 10.1158/1538-7445.Am10-2917 |
0.753 |
|
| 2008 |
Ma WL, Ma CL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S, Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 135: 947-55, 955.e1-5. PMID 18639551 DOI: 10.1053/J.Gastro.2008.05.046 |
0.779 |
|
| 2008 |
Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology (Baltimore, Md.). 47: 1924-35. PMID 18449947 DOI: 10.1002/Hep.22252 |
0.72 |
|
| 2007 |
Kim E, Ma WL, Lin DL, Inui S, Chen YL, Chang C. TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression. Biochemical and Biophysical Research Communications. 361: 323-8. PMID 17655826 DOI: 10.1016/J.Bbrc.2007.06.168 |
0.452 |
|
| 2007 |
Zheng Y, Chen WL, Ma WL, Chang C, Ou JH. Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology. 363: 454-61. PMID 17335866 DOI: 10.1016/J.Virol.2007.01.040 |
0.527 |
|
| 2002 |
Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. The Journal of Biological Chemistry. 277: 43749-56. PMID 12226080 DOI: 10.1074/Jbc.M205603200 |
0.753 |
|
| Show low-probability matches. |